Emergent BioSolutions (EBS) Earnings Date, Estimates & Call Transcripts → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ebs Stock Alerts $2.19 -0.10 (-4.37%) (As of 11:08 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1After Market ClosesConfirmedActual EPS (Mar. 6) -$0.77 Missed By -$0.44 Consensus EPS (Mar. 6) -$0.33 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Emergent BioSolutions Earnings AlertsEnter your email address below to receive the latest news and earnings results for EBS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEBS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EBS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Emergent BioSolutions Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($1.11)($1.11)($1.11) Q2 20241$0.78$0.78$0.78 Q3 20241$0.83$0.83$0.83 Q4 20241$1.59$1.59$1.59 FY 20244$2.09$2.09$2.09 Q1 20251$0.29$0.29$0.29 Q2 20251$1.07$1.07$1.07 EBS Earnings Date and InformationEmergent BioSolutions last posted its earnings results on March 6th, 2024. The biopharmaceutical company reported ($0.77) EPS for the quarter, missing analysts' consensus estimates of ($0.33) by $0.44. The firm earned $276.60 million during the quarter, compared to the consensus estimate of $247.63 million. Emergent BioSolutions has generated ($14.83) earnings per share over the last year (($14.83) diluted earnings per share). Earnings for Emergent BioSolutions are expected to grow in the coming year, from ($13.98) to ($0.25) per share. Emergent BioSolutions has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. Emergent BioSolutions will be holding an earnings conference call on Wednesday, May 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call.. Read More Emergent BioSolutions Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Confirmed)------- 3/6/2024Q4 2023($0.33)($0.77)($0.44)($0.59)$247.63 million$276.60 million 12/11/2023Q3 2023($0.12)($1.44)($1.32)$2.20$255.34 million$270.50 million8/8/2023Q2 2023($0.98)($1.06)($0.08)$3.03$216.17 million$337.90 million 5/9/2023Q1 2023($1.67)($3.17)($1.50)($2.69)$142.85 million$165.10 million 2/27/2023Q4 2022$0.31($0.31)($0.62)$1.14$298.23 million$330.70 million 11/8/2022Q3 2022($0.06)($1.27)($1.21)($1.02)$268.17 million$240.00 million Get the Latest News and Ratings for EBS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emergent BioSolutions and its competitors with MarketBeat's FREE daily newsletter. 8/1/2022Q2 2022$0.63($0.86)($1.49)($0.59)$268.77 million$242.70 million 4/28/2022Q1 2022$0.24$0.18($0.06)$0.43$282.54 million$307.50 million 2/24/2022Q4 2021$3.89$4.50+$0.61$5.50$676.90 million$723.40 million 11/4/2021Q3 2021$2.35($0.36)($2.71)($0.11)$484.77 million$329.00 million 7/29/2021Q2 2021$1.81$0.33($1.48)$0.57$415.73 million$397.50 million 4/28/2021Q1 2021$0.97$1.53+$0.56$1.78$368.62 million$343.00 million Emergent BioSolutions Earnings - Frequently Asked Questions When is Emergent BioSolutions's earnings date? Emergent BioSolutions has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on EBS's earnings history. Did Emergent BioSolutions beat their earnings estimates last quarter? In the previous quarter, Emergent BioSolutions (NYSE:EBS) missed the analysts' consensus estimate of ($0.33) by $0.44 with a reported earnings per share (EPS) of ($0.77). Learn more on analysts' earnings estimate vs. EBS's actual earnings. How can I listen to Emergent BioSolutions's earnings conference call? The conference call for Emergent BioSolutions's latest earnings report can be listened to online. Listen to Conference Call How can I read Emergent BioSolutions's conference call transcript? The conference call transcript for Emergent BioSolutions's latest earnings report can be read online. Read Transcript How can I view Emergent BioSolutions's earnings report? Emergent BioSolutions's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Emergent BioSolutions generate each year? Emergent BioSolutions (NYSE:EBS) has a recorded annual revenue of $1.02 billion. How much profit does Emergent BioSolutions generate each year? Emergent BioSolutions (NYSE:EBS) has a recorded net income of -$760.50 million. EBS has generated -$14.83 earnings per share over the last four quarters. What is Emergent BioSolutions's EPS forecast for next year? Emergent BioSolutions's earnings are expected to grow from ($13.98) per share to ($0.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BOLT Earnings RGLS Earnings FBIO Earnings RIGL Earnings VNDA Earnings VSTM Earnings XOMA Earnings PDSB Earnings IOBT Earnings RNAC Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:EBS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emergent BioSolutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
